These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34849271)

  • 1. Neuronal Ceroid Lipofuscinosis: Clinical and Laboratory Profile in Children from Tertiary Care Centre in South India.
    Gowda VK; Vegda H; Sugumar K; Narayanappa G; Srinivasan VM; Santhoshkumar R; Bhat M; Balu S; Naveen MR
    J Pediatr Genet; 2021 Dec; 10(4):266-273. PubMed ID: 34849271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
    Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
    Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal Ceroid Lipofuscinoses in Children.
    Kamate M; Reddy N; Detroja M; Hattiholi V
    Ann Indian Acad Neurol; 2021; 24(2):192-197. PubMed ID: 34220062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes.
    Jadav RH; Sinha S; Yasha TC; Aravinda H; Gayathri N; Rao S; Bindu PS; Satishchandra P
    Pediatr Neurol; 2014 Jan; 50(1):85-95. PubMed ID: 24120650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Electroencephalogram (EEG) and Magnetic Resonance Imaging (MRI) Findings in Early Recognition and Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 Disease.
    Ho ML; Wirrell EC; Petropoulou K; Sakonju A; Chu D; Seratti G; Palasis S
    J Child Neurol; 2022 Dec; 37(12-14):984-991. PubMed ID: 36184928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease.
    Specchio N; Bellusci M; Pietrafusa N; Trivisano M; de Palma L; Vigevano F
    Epilepsia; 2017 Aug; 58(8):1380-1388. PubMed ID: 28632327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive myoclonic epilepsy: A clinical, electrophysiological and pathological study from South India.
    Sinha S; Satishchandra P; Gayathri N; Yasha TC; Shankar SK
    J Neurol Sci; 2007 Jan; 252(1):16-23. PubMed ID: 17166519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.
    Rosenberg JB; Chen A; Kaminsky SM; Crystal RG; Sondhi D
    Expert Opin Orphan Drugs; 2019; 7(11):473-500. PubMed ID: 33365208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.
    Biswas A; Krishnan P; Amirabadi A; Blaser S; Mercimek-Andrews S; Shroff M
    AJNR Am J Neuroradiol; 2020 Oct; 41(10):1930-1936. PubMed ID: 32855186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.
    Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN
    Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
    Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset childhood neuronal ceroid lipofuscinosis: Early clinical and electroencephalographic markers.
    Beltrán L; Valenzuela GR; Loos M; Vargas R; Lizama R; Spinsanti P; Caraballo R
    Epilepsy Res; 2018 Aug; 144():49-52. PubMed ID: 29778029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations.
    Simonati A; Tessa A; Bernardina BD; Biancheri R; Veneselli E; Tozzi G; Bonsignore M; Grosso S; Piemonte F; Santorelli FM
    Pediatr Neurol; 2009 Apr; 40(4):271-6. PubMed ID: 19302939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal ceroid-lipofuscinoses.
    Bennett MJ; Rakheja D
    Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses.
    Wisniewski KE; Zhong N; Philippart M
    Neurology; 2001 Aug; 57(4):576-81. PubMed ID: 11548735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of the neuronal ceroid lipofuscinoses.
    Mole S; Gardiner M
    Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.
    Miller JN; Kovács AD; Pearce DA
    Hum Mol Genet; 2015 Jan; 24(1):185-96. PubMed ID: 25205113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.